May 24, 2021
Diving deeper into the pharmacy medicine series for pharmacy development and its process, Jackie Lee chats with Jonathan Gray and returning guest Kerri Miller about precision medicine. Learn how manufacturers are beginning to get actuarial and health plan perspectives to enhance their budget-impact models, and how health plans can project new drug costs to enhance their pricing forecasts and negotiations with manufacturers. Actuaries who work with health plans of all sizes can hear about specific resources in identifying populations for a drug, making appropriate assumptions, improving projections, and how to contribute earlier on in the drug development process.